These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 9592351)

  • 21. [Effects of bortezomib combined with daunorubicin on proliferation and apoptosis in primary adult acute leukemia].
    Zhou RQ; Gong YP; Zheng BH; Yang X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):789-92. PubMed ID: 21302442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study on the sensitization of acute myeloid leukemia cell to daunorubicin by recombinant human interleukin-3].
    Wang J; Wang Q; Chen X
    Zhonghua Xue Ye Xue Za Zhi; 1999 Jan; 20(1):30-2. PubMed ID: 11498841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic reversal of multidrug-resistance phenotype in acute myeloid leukemia cells by cyclosporin A and cremophor EL.
    Ross DD; Wooten PJ; Tong Y; Cornblatt B; Levy C; Sridhara R; Lee EJ; Schiffer CA
    Blood; 1994 Mar; 83(5):1337-47. PubMed ID: 8118035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reproducible flow cytometric methodology for measuring multidrug resistance in leukaemic blasts.
    Pallis M; Turzanski J; Langabeer S; Russell NH
    Adv Exp Med Biol; 1999; 457():77-88. PubMed ID: 10500783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multidrug resistance in haematological malignancies.
    Sonneveld P
    J Intern Med; 2000 May; 247(5):521-34. PubMed ID: 10809991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversal of drug-resistance by cyclosporin-A in a patient with acute myelocytic leukaemia.
    Sonneveld P; Nooter K
    Br J Haematol; 1990 Jun; 75(2):208-11. PubMed ID: 2372507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative cellular pharmacology of daunorubicin and idarubicin in human multidrug-resistant leukemia cells.
    Berman E; McBride M
    Blood; 1992 Jun; 79(12):3267-73. PubMed ID: 1596567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular uptake and antiproliferative effects of therapeutic concentrations of idarubicin or daunorubicin and their alcohol metabolites, with or without cyclosporin A, in MDR1+ human leukemic cells.
    Chiodini B; Bassan R; Barbui T
    Leuk Lymphoma; 1999 May; 33(5-6):485-97. PubMed ID: 10342576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study on the relationship between DNA topoisomerase II activity and multidrug resistance in leukemic cells].
    Zheng W; Xie Z; Tang G
    Zhonghua Xue Ye Xue Za Zhi; 1998 Sep; 19(9):470-2. PubMed ID: 11189486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of MDR1/P-170 expression with daunorubicin uptake and sensitivity of leukemic progenitors in acute myeloid leukemia.
    Campos L; Guyotat D; Jaffar C; Solary E; Archimbaud E; Treille D
    Eur J Haematol; 1992 May; 48(5):254-8. PubMed ID: 1353726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Detection and analysis of multidrug resistance in 100 cases of acute leukemia].
    Luan FJ; Yang CZ; Shao XF
    Zhonghua Zhong Liu Za Zhi; 1994 Sep; 16(5):360-3. PubMed ID: 7895588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical studies on expressions of Fas and mdr-1 in acute leukemia and their correlations].
    Ye F; Qiao ZH; Su LP; Ma LM; Zhu L; Zhang L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Aug; 12(4):411-5. PubMed ID: 15363121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apoptosis by anthracyclines at therapeutic concentrations in MDR1+ human leukemic cells.
    Chiodini B; Bassan R; Barbui T
    Adv Exp Med Biol; 1999; 457():313-24. PubMed ID: 10500807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Daunorubicin efflux assay in determining multidrug resistance of patients with acute myeloid leukemia.
    Kim DH; Lee NY; Kim JG; Sohn SK; Won DI; Suh JS; Lee GS; Chae SC; Lee KB
    Leuk Lymphoma; 2005 Jan; 46(1):63-70. PubMed ID: 15621782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance testing and mechanisms of resistance in childhood leukemia. Studies from Amsterdam.
    Pieters R; Kaspers GJ; Ramakers-van Woerden NL; den Boer ML; Rots MG; Zwaan CM; Haarman EG; Veerman AJ
    Adv Exp Med Biol; 1999; 457():391-5. PubMed ID: 10500814
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical study on reversal of multidrug resistance in refractory and relapsed acute leukemias by cyclosporin A].
    Li X; Wu J; Zhang L; Zhu H
    Zhonghua Xue Ye Xue Za Zhi; 1997 Feb; 18(2):73-5. PubMed ID: 15622781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discrimination of Multidrug Resistance in Cancer Cells Achieved Using Single-Cell Analysis.
    Wang H; Zhang R; Yang D; Wang X
    Methods Mol Biol; 2023; 2689():95-106. PubMed ID: 37430049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of the mdr3 gene in prolymphocytic leukemia: association with cyclosporin-A-induced increase in drug accumulation.
    Nooter K; Sonneveld P; Janssen A; Oostrum R; Boersma T; Herweijer H; Valerio D; Hagemeijer A; Baas F
    Int J Cancer; 1990 Apr; 45(4):626-31. PubMed ID: 2323839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The expression of P-170 and chromosomal abnormality in refractory/relapse acute leukemia].
    Lin XM; Xie ZX; Chen ZH
    Hunan Yi Ke Da Xue Xue Bao; 2000 Dec; 25(6):591-2. PubMed ID: 12516418
    [No Abstract]   [Full Text] [Related]  

  • 40. Functional multidrug resistance in acute myeloblastic leukaemia: a standardized flow cytometric assay for intracellular daunorubicin accumulation.
    Pallis M; Russell NH
    Br J Haematol; 1998 Jan; 100(1):194-7. PubMed ID: 9450811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.